Lockheed Martin Corporation (LMT) Receives Average Recommendation of “Buy” from Brokerages

The original version of this report can be accessed at https://www.truebluetribune.com/2017/08/29/royal-bank-of-canada-reiterates-289-00-price-target-for-lockheed-martin-corporation-lmt.html. The rating was maintained by MLV on Friday, July 24 with “Buy”. The firm earned “Buy” rating on Monday, November 9 by Roth Capital. The firm has “Underperform” rating by Credit Agricole given on Thursday, October 29. (NASDAQ:CYTK) earned “Buy” rating by TH Capital on Monday, November 9. As per Thursday, August 3, the company rating was maintained by H.C. Wainwright. Sumitomo Mitsui Holdings reported 0.31% stake. The stock of SYNNEX Corporation (NYSE:SNX) earned “Underperform” rating by CLSA on Thursday, October 29. Bank Of Ny Mellon stated it has 2.41 million shares. Us Bancorp De holds 0.12% or 133,701 shares. Fairfield Bush And has 0.17% invested in Lockheed Martin Corporation (NYSE:LMT). The stock rose 1.41% or $4.29 reaching $307.9. About 257,480 shares traded. Morgan Stanley initiated coverage on Lockheed Martin Corporation in a research report on Tuesday, August 8th. It has underperformed by 2.51% the S&P500.The move comes after 5 months positive chart setup for the $88.46B company.

Among 9 analysts covering Cytokinetics (NASDAQ:CYTK), 9 have Buy rating, 0 Sell and 0 Hold. Therefore 58% are positive.

Lockheed Martin Corporation is a security and aerospace company. On average, analysts predict that Lockheed Martin Corporation will post $12.64 earnings per share for the current fiscal year. Barclays Capital downgraded Lockheed Martin Corporation (NYSE:LMT) on Monday, November 30 to “Underweight” rating. The company was downgraded on Tuesday, January 12 by RBC Capital Markets. The brokerage now has a hold rating on the aerospace company’s stock. Lockheed Martin Corporation now has an average rating of Buy and an average target price of $298.10.

Lockheed Martin Corporation (NYSE:LMT) last released its earnings results on Tuesday, July 18th. As per Friday, January 22, the company rating was upgraded by BMO Capital Markets.

Investors sentiment increased to 2.94 in Q4 2016. Its down 0.44, from 1.58 in 2016Q3. It is positive, as 49 investors sold Lockheed Martin Corporation shares while 363 reduced holdings. 126 funds opened positions while 368 raised stakes. Atria Investments Lc reported 557 shares or 0.02% of all its holdings. Capstone Asset Mngmt holds 943 shares or 0.01% of its portfolio. Lenox Wealth holds 650 shares or 0.01% of its portfolio. Millennium Management accumulated 0.25% or 479,616 shares.

Among 19 analysts covering Lockheed Martin Corporation (NYSE:LMT), 11 have Buy rating, 0 Sell and 8 Hold. Meeder Asset reported 2,003 shares. The stock of Lockheed Martin Corporation (NYSE:LMT) earned “Buy” rating by Drexel on Wednesday, October 21. Lockheed Martin Corporation has a 52-week low of $228.50 and a 52-week high of $308.48. Deutsche Bancorporation Ag holds 48,481 shares. Dynamic Cap Mgmt Limited has 3,332 shares. In the last ninety days, insiders have sold 45,220 shares of company stock valued at $13,293,563. Asset Corp accumulated 51 shares or 0% of the stock.

Passport Capital Llc increased Habit Restaurants Inc stake by 341,602 shares to 1.34M valued at $23.14M in 2016Q4. Ledyard National Bank owns 75 shares. Raytheon Co (NYSE:RTN) was raised too. About 8,959 shares traded. Cytokinetics Inc now has $748.65 million valuation.

Investors sentiment decreased to 1.14 in 2016 Q4. Its up 0.06, from 1.01 in 2016Q3. Blackrock Fund Advisors holds 0.03% of its portfolio in NewMarket Corporation (NYSE:NEU) for 351,692 shares. 17 funds opened positions while 24 raised stakes. Lansdowne Ptnrs (Uk) Llp has invested 0.25% in Cytokinetics, Inc. (NASDAQ:CYTK) for 20,000 shares. Assetmark Inc holds 34 shares. (NASDAQ:CYTK) for 19,472 shares. Moreover, Wade G W & has 0.04% invested in Cytokinetics, Inc. Edgestream Partners Lp sold 18,889 shares as the company’s stock rose 2.80% with the market. Pnc Fin reported 169,216 shares. The stock of Cytokinetics, Inc. New Jersey-based Jacobs Levy Equity Management has invested 0.18% in SYNNEX Corporation (NYSE:SNX). The New York-based Engineers Gate Manager L P has invested 0.19% in Lockheed Martin Corporation (NYSE:LMT). (NASDAQ:CYTK) or 97,705 shares. Services Automobile Association reported 0% of its portfolio in SYNNEX Corporation (NYSE:SNX).

Cytokinetics, Incorporated is a late-stage biopharmaceutical company. The company has a market capitalization of $87.44 billion, a PE ratio of 17.62 and a beta of 0.60. It now has negative earnings. Shares for $68,093 were sold by Blum Robert I on Thursday, June 1.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *